insights_auto
Nega GENB oshdi 3,90%?
Batafsil oʻrganishchevron_right
GENB:NASDAQ
Generate Biomedicines Inc
13,06 US$
arrow_upward
+3,90%(+0,49) 1K
6-noy, 16:00:01 (GMT-5) · USD
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoGENB tikeri uchun statistika yaratilmoqda...
Ochish
12,90 US$
Yuqori
13,17 US$
Past
12,47 US$
Bozor kapitali
1,68 mlrd
Oʻrtacha hajm
1,04 mln
Hajmi
632,20 ming
52 haftalik eng yuqori
22,67 US$
52 haftalik eng past
11,00 US$
Xodimlar soni
312
Ochish
12,90 US$
Yuqori
13,17 US$
Past
12,47 US$
Bozor kapitali
1,68 mlrd
Oʻrtacha hajm
1,04 mln
Hajmi
632,20 ming
52 haftalik eng yuqori
22,67 US$
52 haftalik eng past
11,00 US$
Xodimlar soni
312
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
The Business Journal
·
5 soat oldin
AI stocks bounce back as S&P 500 trims weekly loss to 2.7%
MarketWatch
·
15 soat oldin
The S&P 500’s most reliable dividend stocks are beating the market. Here’s how to play them.
Barron's
·
15 soat oldin
S&P 500 Futures Rise in Premarket Trading; JFrog, Cloudflare Lead
Yahoo Finance
·
17 soat oldin
iShares Core S&P 500 (IVV) Buys $394.7 Million More Oracle on Nov. 4
Profil
Generate:Biomedicines is a biotechnology company founded in 2018 and headquartered in Somerville, Massachusetts. It specializes in using machine learning to design and optimize proteins for therapeutic applications, with a focus on immunology, oncology, and infectious diseases. Wikipedia
Generate Biomedicines Inc haqida
CEO-
Xodimlar soni312
Asos solingan2018
Bosh ofislarSomerville, Massachusetts, Amerika Qo‘shma Shtatlari
SektorHealth Care
Soha-
Veb-saytgeneratebiomedicines.com